Jump to Content
Jump to Main Navigation
HOME
BROWSE
SUBJECTS
CLINICAL RESOURCES
DRUG INFORMATION
EDUCATION AND TRAINING
PHARMACY PRACTICE
CAREER DEVELOPMENT
AJHP
DRUG INFORMATION
PROFESSIONAL DEVELOPMENT
Sign in
Sign up
SEARCH
Advanced Search
Help
Sign in
Sign up
HOME
BROWSE
SUBJECTS
CLINICAL RESOURCES
DRUG INFORMATION
EDUCATION AND TRAINING
PHARMACY PRACTICE
CAREER DEVELOPMENT
AJHP
DRUG INFORMATION
PROFESSIONAL DEVELOPMENT
SEARCH
Advanced Search
Help
Search
Table of Contents
Front Matter
Preliminary Material
PART I. Anticoagulation Medication Management
1. Introduction to Anticoagulation Management
2. Warfarin
3. Unfractionated Heparin
4. Low Molecular Weight Heparin and Fondaparinux
5. Parenteral Direct Thrombin Inhibitors
6. Thrombolytic Considerations When Used with Anticoagulants
7. Direct Oral Anticoagulants
8. Anticoagulation Reversal: Part I—Pharmacology of Agents Used for Reversal
9. Anticoagulation Reversal: Part II—Clinical Application
10. Transitions in Care—Periprocedural Bridging and Transitions Between Agents
11. Considerations in Special Populations
PART II. Conditions Requiring Anticoagulation Therapy
12. Venous Thromboembolism Prevention
13. Venous Thromboembolism Treatment
14. Atrial Fibrillation
15. Acute Coronary Syndromes
16. Prosthetic Heart Valves
17. Mechanical Circulatory Support Devices
18. Heparin-Induced Thrombocytopenia
19. Pregnancy
20. Pediatrics
PART III. Practical Measuring, Monitoring, and Coagulation Laboratory Insights
21. Coagulation Laboratory Considerations
22. Thrombophilias
PART IV. Essentials for Practice Success
23. Models and Standards of Anticoagulation Care Delivery
24. Regulatory and Practice Resources
Back Matter
Appendix A.
Coagulation Cascade
Appendix B.
Agents Implicated in Drug-Induced Thromboembolic Diseases
Appendix C.
Nutrition Influence on Anticoagulation
Appendix D.
Anticoagulants in Management of Ischemic Stroke or Transient Ischemic Attacks
Appendix E.
Citrate Anticoagulation
Appendix F.
Examples of Available Bleeding Definitions
Appendix G.
Types of CNS Hemorrhage
Appendix H.
Disseminated Intravascular Coagulation
Appendix I.
Nondrug Causes of Thrombocytopenia
Appendix J.
Drug-Related Causes of Thrombocytopenia
Appendix K.
Examples of Transfusion-Related Reactions
Appendix L.
Considerations for Transitioning from aPTT to Anti-Xa to Manage Heparin Therapy
Appendix M.
PIONEER AF-PCI
Appendix N.
Betrixaban APEX Trial
Index
22. Thrombophilias
in
Anticoagulation Therapy
Authors:
Jessica B. Michaud
and
Canice A. Coan
DOI:
https://doi.org/10.37573/9781585284900.022
Restricted access
PDF Preview
Email this content
Share Link
Copy this link, or click below to email it to a friend
Email this content
or copy the link directly:
https://publications.ashp.org/abstract/book/9781585284900/ch022.xml
The link was not copied. Your current browser may not support copying via this button.
Link copied successfully
Copy link
[34.232.62.64]
34.232.62.64
Sign in to annotate
Close
Edit
Character limit
500
/500
Delete
Cancel
Save
@!
Character limit
500
/500
Cancel
Save
View Expanded
View Table
View Full Size
